Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256412 · ClinicalTrials.gov registry record · NA
Essential Fatty Acids for Major Depression
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00256412 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 24 participants.
The verdict
NCT00256412, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a research study to determine whether omega-3 fatty acid supplementation, when taken with the antidepressant medication escitalopram (Lexapro), helps to improve depressive symptoms in individuals who have major depressive disorder (MDD). Omega-3 fatty acids are found in foods including walnuts, some fruits and vegetables, and coldwater fish such as herring, mackerel, sturgeon, and anchovies.
Interventions
- DRUG Placebo
- DRUG Eicosapentaenoic acid (EPA) 0.7 grams/day or 1.5 grams/day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00256412
The ClinicalTrials.gov registry entry for NCT00256412 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00256412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00256412 about?
NCT00256412 is a clinical study titled "Essential Fatty Acids for Major Depression". This is a research study to determine whether omega-3 fatty acid supplementation, when taken with the antidepressant medication escitalopram (Lexapro), helps to improve depressive symptoms in individuals who have major depressive disorder (MDD). Omega-3 fatty acids are found in foods including waln...
What is the current status of trial NCT00256412?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2005-10. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00256412?
The interventions under investigation include: Placebo (DRUG), Eicosapentaenoic acid (EPA) 0.7 grams/day or 1.5 grams/day (DRUG).
Who is sponsoring clinical trial NCT00256412?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.